Trials / Completed
CompletedNCT00971061
Ahmed Glaucoma Valve and Single-Plate Molteno Implants in Treatment of Refractory Glaucoma
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- Vanak Eye Surgery Center · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the efficacy and safety of the Ahmed valve implant (AVI) and the Molteno single-plate implant (MSPI) in eyes with refractory glaucoma during a follow-up period of 24 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ahmed valve implant | 184 mm2 surface area Ahmed Glaucoma Valve (AGV Model FP7; New World Medical Inc., Rancho Cucamonga, California, USA) |
| DEVICE | Molteno single-plate implant (MSPI) | 134 mm2 surface area single-plate Molteno implant (Molteno Ophthalmic Limited, Dunedin, New Zealand) |
Timeline
- Start date
- 2003-01-01
- Primary completion
- 2005-08-01
- Completion
- 2005-08-01
- First posted
- 2009-09-03
- Last updated
- 2009-09-04
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT00971061. Inclusion in this directory is not an endorsement.